Incannex Healthcare Inc. (NASDAQ:IXHL – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 120,600 shares, an increase of 6.3% from the August 31st total of 113,400 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is presently 4.0 days. Currently, 0.9% of the shares of the stock are sold short.
Incannex Healthcare Stock Performance
Incannex Healthcare stock opened at $1.68 on Wednesday. The business has a 50 day simple moving average of $1.87 and a 200-day simple moving average of $2.51. Incannex Healthcare has a 12 month low of $0.80 and a 12 month high of $12.68.
Institutional Investors Weigh In On Incannex Healthcare
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AdvisorShares Investments LLC acquired a new position in shares of Incannex Healthcare during the 4th quarter worth about $180,000. Tidal Investments LLC acquired a new position in shares of Incannex Healthcare during the first quarter valued at approximately $1,520,000. Finally, Virtu Financial LLC purchased a new position in shares of Incannex Healthcare in the first quarter valued at approximately $39,000. Hedge funds and other institutional investors own 0.43% of the company’s stock.
Incannex Healthcare Company Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
See Also
- Five stocks we like better than Incannex Healthcare
- Retail Stocks Investing, Explained
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.